GTC Biotherapeutics Reports Third Quarter 2010 Financial Results

Published: Oct 28, 2010

FRAMINGHAM, Mass.--(BUSINESS WIRE)--In the Selected Financial Information, under Net income (loss) per common share - Diluted, the Three Months Ended September 30, 2010 should read: $0.05 (sted $0.39). Under Weighted average number of shares outstanding - Diluted, the Three Months Ended September 30, 2010 should read: 77,670 (sted 8,943).

Back to news